Concepedia

Durable HIV-1 Suppression with Indinavir after Failing Lamivudine-Containing Double Nucleoside Therapy: A Randomized Controlled Trial

Norbert A. Foudraine, Suzanne Jurriaans, Gerrit Jan Weverling, David M. Burger, Richard M. W. Hoetelmans, Marijke TL Roos, Jaap Maas, Frank Miedema, Peter Reiss, Peter Portegies,

Antiviral Therapy · 2001 · 10 citations · 39 references

DOIFull text

Open access

Abstract

The long-term HIV-1 suppression observed in this study is remarkable, as adding a single antiretroviral agent to a failing regimen goes against current notions of adequate therapy.

References

39

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

Frank J. Palella, Kathleen M. Delaney, Anne C. Moorman et al. · New England Journal of Medicine · 1998 · 9.5K citations

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Scott M. Hammer, Kathleen Squires, Michael D. Hughes et al. · New England Journal of Medicine · 1997 · 2.7K citations · Full text

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Roy M. Gulick, John W. Mellors, Diane V. Havlir et al. · New England Journal of Medicine · 1997 · 1.9K citations · Full text

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

Richard B. Kim, Martin F. Fromm, Christoph Wandel et al. · Journal of Clinical Investigation · 1998 · 1.1K citations · Full text

, , +17

A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients

Julio Montaner, David A. Cooper, Stefano Vella et al. · JAMA · 1998 · 771 citations